US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 3.440
  • +0.020+0.58%
Trading Nov 26 11:08 ET
651.85MMarket Cap-8000P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arbutus Biopharma Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.90M
1.34M
-563.66K
Miss Est.
-59.46%
-71.25%
-29.63%
EPS
-0.10
-0.10
-<0.01
Miss Est.
+20.78%
+16.67%
-4.49%
Analyst Rating
Strong Buy

Nov 19, 2024

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.971M--
--2024/Q4-- / 2.211M--
Nov 6, 20242024/Q31.855M / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.971M--
--2024/Q4-- / 2.211M--
Nov 6, 20242024/Q31.855M / 2.573M--
Aug 1, 20242024/Q22.390M / 2.415M--
May 2, 20242024/Q12.108M / 3.682M--

Unlock Free Earnings Estimates

Arbutus Biopharma Earnings Reports

  • Arbutus Biopharma | 10-Q: Q3 2024 Earnings Report

    Nov 6 16:10 ET

  • Arbutus Biopharma | 8-K: Arbutus Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 6 07:37 ET

  • Arbutus Biopharma | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:53 ET

  • Arbutus Biopharma | 8-K: Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 1 07:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 19, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data